| Today's Open | $32.73 |
|---|---|
| Previous Close | $32.53 |
| Daily Range | $32.35 - $33.14 |
| 52-Week Range | $21.04 - $40.87 |
| Market Cap | $1.3B |
| P/E Ratio | 8.99 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 381,696 |
| Average Daily Volume | 594,556 |
| Current FY EPS | $0.24 |
Sector
Healthcare
Industry
Drugs
Acorda Therapeutics, Inc. (ACOR) Description
A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS. Website: http://www.acorda.com/
News & Commentary
ACOR's Top Competitors
(1.26%)
(0.63%)
(2.44%)
(-0.50%)